Suchergebnisse - "Neurath, Markus F"

PubPharm (15)

1

Inhibiting PGGT1B Disrupts Function of RHOA, Resulting in T-cell Expression of Integrin α4β7 and Development of Colitis in Mice

enthalten in: Gastroenterology | 2019

von López-Posadas, R. | Fastancz, P. | Martínez-Sánchez, L. | +17

2

Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation

enthalten in: Gastroenterology | 2019

von Scheibe, K. | Kersten, C. | Schmied, A. | +21

CommentIn: Gastroenterology. 2019 Mar;156(4):871-873. - PMID 30776349

3

IL-23 in inflammatory bowel diseases and colon cancer

enthalten in: Cytokine & growth factor reviews | 2019

von Neurath, M.

4

Oligonucleotides-A Novel Promising Therapeutic Option for IBD

enthalten in: Frontiers in pharmacology | 2019

von Scarozza, P. | Schmitt, H. | Monteleone, G. | +2

5

Top-down approach to biological therapy of Crohn's disease

enthalten in: Expert opinion on biological therapy | 2017

von Hirschmann, S. | Neurath, M.

6

Microbiota : relevant player in thiopurine metabolisation?

enthalten in: Gut | 2017

von Atreya, I. | Neurath, M.

CommentOn: Gut. 2017 Jan;66(1):59-69. - PMID 27411368

7

Th9 cells in inflammatory bowel diseases

enthalten in: Seminars in immunopathology | 2017

von Weigmann, B. | Neurath, M.

8

Th9 cells in inflammatory bowel diseases

enthalten in: Seminars in immunopathology | 2016

von Weigmann, B. | Neurath, M.

9

Th9 cells in inflammatory bowel diseases

enthalten in: Seminars in immunopathology | 2016

von Weigmann, B. | Neurath, M.

10

Th9 cells in inflammatory bowel diseases

enthalten in: Springer Seminars in immunopathology | 2016

von Weigmann, B. | Neurath, M.